Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thymoglobulin Conditioning in Cadaveric Renal Donors
NCT01939171Phase 2Completed
- Sponsor
- Hospital La Paz Institute for Health Research
- Start
- Jun 2010
- Primary completion
- Feb 2012
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 2
01
Overview
Phase 2, randomised, single-blind trial of antithymocyte globulin in kidney transplant rejection and delayed graft function (DGF) (2 arms), sponsored by Hospital La Paz Institute for Health Research. Primary endpoints: Efficacy of Thymoglobuline in cadaveric donor at 2 days and Security of Thymoglobuline in cadaveric donor at 1 day. Started Jun 2010; status: completed.
02
Drugs
antithymocyte globulin
03
Conditions
kidney transplant rejectiondelayed graft function (DGF)
Beyond the preview
Go deeper on NCT01939171.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01939171.